MX2021006987A - Composiciones y metodos para el tratamiento de "placas y ovillos" en seres humanos y animales. - Google Patents

Composiciones y metodos para el tratamiento de "placas y ovillos" en seres humanos y animales.

Info

Publication number
MX2021006987A
MX2021006987A MX2021006987A MX2021006987A MX2021006987A MX 2021006987 A MX2021006987 A MX 2021006987A MX 2021006987 A MX2021006987 A MX 2021006987A MX 2021006987 A MX2021006987 A MX 2021006987A MX 2021006987 A MX2021006987 A MX 2021006987A
Authority
MX
Mexico
Prior art keywords
tangles
plaques
methods
humans
animals
Prior art date
Application number
MX2021006987A
Other languages
English (en)
Inventor
Alan Snow
Original Assignee
Cognitive Clarity Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cognitive Clarity Inc filed Critical Cognitive Clarity Inc
Publication of MX2021006987A publication Critical patent/MX2021006987A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/74—Rubiaceae (Madder family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/82—Theaceae (Tea family), e.g. camellia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Medical Informatics (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Psychiatry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hospice & Palliative Care (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

Composición y métodos para tratar "placas" y/o "ovillos" cerebrales en un sujeto en el que el método comprende la administración de una cantidad terapéuticamente eficaz de una composición que comprende un extracto de grosella negra, un extracto de Uncaria tomentosa y un extracto de té oolong.
MX2021006987A 2018-12-12 2019-11-26 Composiciones y metodos para el tratamiento de "placas y ovillos" en seres humanos y animales. MX2021006987A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201862778875P 2018-12-12 2018-12-12
PCT/US2019/063455 WO2020123152A1 (en) 2018-12-12 2019-11-26 Compositions and methods for the treatment of "plaques and tangles" in humans and animals

Publications (1)

Publication Number Publication Date
MX2021006987A true MX2021006987A (es) 2021-08-11

Family

ID=71071419

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2021006987A MX2021006987A (es) 2018-12-12 2019-11-26 Composiciones y metodos para el tratamiento de "placas y ovillos" en seres humanos y animales.

Country Status (12)

Country Link
US (1) US11491201B2 (es)
EP (1) EP3893907A4 (es)
JP (1) JP2022512372A (es)
CN (1) CN113301906A (es)
AU (1) AU2019397260A1 (es)
CA (1) CA3122687A1 (es)
CO (1) CO2021008890A2 (es)
DO (1) DOP2021000110A (es)
MX (1) MX2021006987A (es)
PH (1) PH12021551342A1 (es)
SG (1) SG11202106222YA (es)
WO (1) WO2020123152A1 (es)

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5683698A (en) * 1996-08-02 1997-11-04 New England Deaconess Hospital Formulation for alleviating symptoms associated with arthritis
US6264994B1 (en) 1997-05-15 2001-07-24 University Of Washington Compositions for treating alzheimer's disease and other amyloidoses
CA2289531C (en) 1997-05-15 2009-09-29 University Of Washington Composition and methods for treating alzheimer's disease and other amyloidoses
US6346280B1 (en) 1997-05-15 2002-02-12 University Of Washington Composition and methods for inhibiting the formation of brain amyloid deposits
CA2323090C (en) 1998-03-13 2009-08-04 University Of Washington In vitro formation of congophilic maltese-cross amyloid plaques to identify anti-plaque therapeutics for the treatment of alzheimer's and prion diseases
JP2003171298A (ja) 2001-12-11 2003-06-17 Nonogawa Shoji Kk 抗アレルギー剤
US8034387B2 (en) 2002-04-30 2011-10-11 Unigen, Inc. Formulation of a mixture of free-B-ring flavonoids and flavans for use in the prevention and treatment of cognitive decline and age-related memory impairments
US7244764B2 (en) * 2003-06-23 2007-07-17 Neurochem (International) Limited Methods and compositions for treating amyloid-related diseases
US20070190075A1 (en) 2003-10-09 2007-08-16 Advangen, Inc. C/O National Institute Of Advance Science And Tech Hair growth stimulant composition
WO2005094770A1 (en) * 2004-03-30 2005-10-13 Unilever Plc Skin lightening compositions comprising vitamines and flavonoids
JP4321769B2 (ja) 2004-04-13 2009-08-26 Ｔｏｗａ Ｃｏｒｐｏｒａｔｉｏｎ 株式会社 抗ヒスタミン用組成物、アレルギ性鼻炎の予防および治療用組成物、花粉症の予防および治療用組成物およびじんま疹治療用組成物
JP4954552B2 (ja) 2006-01-07 2012-06-20 日本メナード化粧品株式会社 抗アレルギー剤
JP2007230977A (ja) 2006-03-03 2007-09-13 Naris Cosmetics Co Ltd 顆粒球・マクロファージコロニー刺激因子（ｇｍ−ｃｓｆ）産生抑制剤ｉｉ
JP2007277163A (ja) 2006-04-06 2007-10-25 Uha Mikakuto Co Ltd ジペプチジルペプチダーゼｉｖ阻害剤
TW200812637A (en) 2006-09-15 2008-03-16 jun-er Wang Vegetable composition for cleaning oral cavity
JP2010013423A (ja) 2008-07-07 2010-01-21 Lion Corp ジペプチジルペプチダーゼ−ｉｖ阻害剤
JP5688606B2 (ja) * 2012-02-17 2015-03-25 株式会社シェフコ 機能性原料を含有する水素含有飲料の製造方法
SG11201706861QA (en) * 2015-02-27 2017-09-28 Cognitive Clarity Inc Compositions and methods for the treatment of "plaques and tangles" in humans and animals
KR20190008300A (ko) * 2016-05-17 2019-01-23 알파젠 엔지 리미티드 L-테아닌, 프로안토시아니딘 및 카테킨을 포함하는 조성물 및 그 용도
WO2018022828A1 (en) 2016-07-29 2018-02-01 The Procter & Gamble Company Catalysts for making acrylic acid from lactic acid or its derivatives in liquid phase

Also Published As

Publication number Publication date
CO2021008890A2 (es) 2021-07-30
CA3122687A1 (en) 2020-06-18
US11491201B2 (en) 2022-11-08
AU2019397260A1 (en) 2021-06-24
JP2022512372A (ja) 2022-02-03
EP3893907A1 (en) 2021-10-20
US20200188467A1 (en) 2020-06-18
WO2020123152A1 (en) 2020-06-18
PH12021551342A1 (en) 2021-12-13
DOP2021000110A (es) 2021-12-15
SG11202106222YA (en) 2021-07-29
EP3893907A4 (en) 2022-11-30
CN113301906A (zh) 2021-08-24

Similar Documents

Publication Publication Date Title
MX2020001732A (es) Tratamiento de las afecciones del sistema nervioso central.
MX2021000071A (es) Uso de pridopidina para mejorar la funcion cognitiva y para tratamiento de enfermedad de alzheimer.
MY179696A (en) Compositions and methods comprising bupropion or related compounds and dextromethorphan
MX2020001403A (es) Nuevos derivados de quinolina.
MX2019014548A (es) Derivado de n2,n4-difenilprimidin-2,4-diamina, metodo para la preparacion del mismo, y una composicion farmaceutica que contiene el mismo como ingrediente activo para la prevencion o tratamiento de cancer.
EP4324454A3 (en) Cross-linking agents and associated methods
MX2020002884A (es) Método y composición neuroprotectora mejorada para tratar afecciones neurológicas.
MX2020010908A (es) Composiciones infundidas con compuestos de nicotina y metodos de uso de las mismas.
MX2019008124A (es) Metodos para el tratamiento de trastornos neurologicos.
SG11201903725UA (en) Composition for promoting differentiation of and protecting neural stem cells and method for inducing neural regeneration using same
MX2021002916A (es) Pirfenidona enriquecida con deuterio y métodos para su uso.
MX2024000349A (es) Compuestos y usos de los mismos.
MX2019009586A (es) Composiciones y metodos para tratar enfermedades asociadas con la permeabilidad del epitelio intestinal.
SG11201908234WA (en) Pharmaceutical composition comprising compound capable of penetrating blood-brain barrier as effective ingredient for preventing or treating brain cancer
MX2021011488A (es) Compuestos y usos de estos.
SA113340494B1 (ar) تركيبة لعلاج اضطرابات أيضية
MX2017010873A (es) Composiciones y métodos para el tratamiento de "placas y ovillos" en humanos y animales.
MX2021002012A (es) Metodos de tratamiento del trastorno por estres agudo y trastorno por estres postraumatico.
MX2024006768A (es) Compuestos y usos de los mismos.
PH12021551342A1 (en) Compositions and methods for the treatment of "plaques and tangles" in humans and animals
WO2014116015A3 (ko) 자죽염을 포함하는 알츠하이머병 예방용 조성물 및 자죽염의 제조방법
EP3556373C0 (en) COMPOSITION WITH SEA CUCUMBER EXTRACT AS ACTIVE INGREDIENT FOR THE PREVENTION AND TREATMENT OF DYSFUNCTIONAL BRUCH MEMBRANE DISEASE
WO2019232203A3 (en) Methods and compositions to alleviate vascular permeability
PH12019502145A1 (en) Agent for preventing myopia, treating myopia, and/or preventing myopia progression comprising tiotropium as active ingredient
MX2021001228A (es) Composicion para uso en la prevencion y/o tratamiento de la mucosa genitourinaria.